Lakefront Biotherapeutics NV (G1LP34.SA) Q3 2024 Earnings

1AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-10.58
-2.78
5.03
12.84

Details

Expected EPS
-0.421648072229088
Actual EPS
0.6478156287795841
Surprise EPS
1.07
Surprise Percent
+253.64%

Description

Lakefront Biotherapeutics NV (G1LP34.SA) has reported earnings of 0.6478156287795841 per share for Q3 2024.

0 Comments

Share your thoughts